Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer.

The only widely used screening test for early detection of colorectal cancer, the fecal occult blood test, lacks both sensitivity and specificity because it relies upon incidental bleeding rather than the neoplastic process. With the purpose of developing a new noninvasive diagnostic approach, we quantified DNA extracted from cells isolated from the surface of human stools by a novel procedure. Stools collected from 28 healthy individuals, 17 colorectal cancer patients, and 11 colorectal polyp patients were analyzed. A stool DNA index (SDNAI), expressed as DNA amount in nanograms per gram of stool, had a remarkable 4.5-fold difference in mean values between colorectal cancer patients and healthy people of comparable age. SDNAI was 2133 +/- 407 in the cancer group versus 469 +/- 65 in healthy people of the older (> 50 years) age group (P = 0.0005). The difference was independent of tumor location and size. If 700 ng of DNA/g of stool was taken as a cutoff SDNAI value in discrimination between older healthy people and cancer patients, sensitivity and specificity values reached 1.00 and 0.81, respectively. Age dependence of SDNAI was demonstrated by substantially lower SDNAI values (mean, 227 +/- 41) in younger healthy individuals. Polyp patients sometimes displayed elevated SDNAI values, but considerable variation was observed (mean, 1215 +/- 548). These preliminary findings indicate that SDNAI provides a novel, simple, and powerful noninvasive test for colorectal cancer early detection and screening. The fundamental advantage of the SDNAI is that it directly characterizes colonic epithelium involved in carcinogenesis.

[1]  A. Feinberg,et al.  Microallelotyping defines the sequence and tempo of alleiic losses at tumour suppressor gene loci during colorectal cancer progression , 1995, Nature Medicine.

[2]  W. Bodmer,et al.  Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. , 1995, Gut.

[3]  J. Klein,et al.  Local Hormone Networks and Intestinal T Cell Homeostasis , 1997, Science.

[4]  K. Kinzler,et al.  Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. , 1992, Science.

[5]  C. Wagener,et al.  Detection of K‐ras mutations in stools of patients with colorectal cancer by mutant‐enriched PCR , 1996, International journal of cancer.

[6]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[7]  M. Lipkin,et al.  Correlations between rectal mucosa cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine. , 1991, Cancer research.

[8]  P. Nair,et al.  Isolation of exfoliated colonic epithelial cells, a novel, non‐invasive approach to the study of cellular markers , 1992, International journal of cancer.

[9]  Robert J. Mayer,et al.  Erratum: Colorectal cancer screening: Clinical guidelines and rationale (Gastroenterology (1997) 112 (594-642)) , 1997 .

[10]  F. V. von Eyben,et al.  Colorectal cancer screening: clinical guidelines and rationale. , 1997, Gastroenterology.

[11]  S. Dutta,et al.  Increased expression of CD44 in isolated fecal colonocytes in patients with colonic neoplasia , 1995 .

[12]  J. Califano,et al.  11:40 AM: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996 .

[13]  A. Zauber,et al.  Accuracy of Fecal Occult Blood Test Interpretation , 1991 .

[14]  David E. Housman,et al.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.

[15]  Fergus Shanahan,et al.  A gut reaction: lymphoepithelial communication in the intestine. , 1997, Science.

[16]  K. Mostov,et al.  NH2-terminal Deletion of β-Catenin Results in Stable Colocalization of Mutant β-Catenin with Adenomatous Polyposis Coli Protein and Altered MDCK Cell Adhesion , 1997, The Journal of cell biology.

[17]  G. Papanicolaou,et al.  The application of cytology in the diagnosis of cancer of the rectum, sigmoid, and descending colon , 1952, Cancer.

[18]  V. Weaver,et al.  Extracellular matrix: the central regulator of cell and tissue homeostasis. , 1997, Trends in cell biology.

[19]  A. Adrain,et al.  A comparison of fecal occult-blood tests for colorectal-cancer screening. , 1996, The New England journal of medicine.

[20]  A. Rebecchi,et al.  Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool. , 1996, Gastroenterology.

[21]  Erwin G. Van Meir Hypoxia-mediated selection of cells with diminished apoptotic potential to solid tumours. , 1996, Neurosurgery.

[22]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[23]  K. Matsuo,et al.  Histochemistry of the surface mucous gel layer of the human colon. , 1997, Gut.

[24]  P. Nair,et al.  Human stools as a source of viable colonic epithelial cells , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  R. Sampliner,et al.  Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer risk. , 1996, Cancer research.

[26]  S. Piantadosi,et al.  Poster 7: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996, Cancer research.

[27]  T. Tong,et al.  Cancer statistics, 1994 , 1994, CA: a cancer journal for clinicians.

[28]  O. Yoshida,et al.  Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. , 1997, Journal of the National Cancer Institute.

[29]  D. Greegor Diagnosis of large-bowel cancer in the asymptomatic patient. , 1967, JAMA.

[30]  J. Kirsner,et al.  Exfoliative cytology in diagnosis of cancer of the colon , 1959, Diseases of the colon and rectum.

[31]  B. Warren,et al.  Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. , 1997, British Journal of Cancer.

[32]  W. Bodmer The Somatic Evolution of Cancer , 1997, Journal of the Royal College of Physicians of London.

[33]  Early detection of cancer-associated gene alterations in DNA isolated from rat feces during intestinal tumor-induction with 1,2-dimethylhydrazine. , 1995, International journal of oncology.

[34]  J. Califano,et al.  Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. , 1996, Cancer research.

[35]  O. Terpstra,et al.  Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. , 1987, Gastroenterology.

[36]  Y. Wax,et al.  Oral calcium suppresses increased rectal epithelial proliferation of persons at risk of colorectal cancer. , 1989, Gut.

[37]  D. Slaughter,et al.  “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.